#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16274	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2609	768.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	2010	2010	T	1077	T,G,C	1073,3,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16274	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2609	768.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1744	1744	C	1040	C,G,A	1038,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16274	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2609	768.2	0	HET	.	.	.	A69G	.	69	69	A	629	629	A	1026	A,G	799,223	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28610	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3989	892.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1871	1871	A	1100	A,C	1099,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28610	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3989	892.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2505	2505	C	1019	C,T,A	1016,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28610	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3989	892.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2579	2579	A	974	A,T	972,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28610	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3989	892.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3131	3131	C	1013	C,T,G	1009,3,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	2358	folP	852	852	99.88	folP.l15.c4.ctg.1	2056	143.0	0	.	p	.	0	E151K	NONSYN	451	453	GAA	996	998	AAA	245;243;241	A;A;A,C	245;243;240,1	.	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	2358	folP	852	852	99.88	folP.l15.c4.ctg.1	2056	143.0	1	SNP	p	R228S	1	.	.	682	684	AGC	1227	1229	AGC	240;241;241	A,C;G;C	239,1;241;241	folP.WHO_M_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5410	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3913	172.4	1	SNP	p	S91F	0	.	.	271	273	TCC	807	809	TCC	174;176;179	T;C;C	174;176;179	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5410	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3913	172.4	1	SNP	p	D95G	0	.	.	283	285	GAC	819	821	GAC	186;188;188	G;A,T;C	186;187,1;188	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5410	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3913	172.4	1	SNP	p	D95N	0	.	.	283	285	GAC	819	821	GAC	186;188;188	G;A,T;C	186;187,1;188	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	2134	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1839	144.6	1	SNP	p	G45D	0	.	.	133	135	GGC	795	797	GGC	246;246;250	G;G,A;C	246;245,1;250	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	812	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c4.ctg.1	1462	69.3	0	.	n	.	0	G15A	SNP	15	15	G	564	564	A	30	A,G	29,1	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	812	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c4.ctg.1	1462	69.3	0	.	n	.	0	A197.	DEL	197	197	A	745	745	A	235	A	235	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5518	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3356	204.7	1	SNP	p	D86N	0	.	.	256	258	GAC	752	754	GAC	252;255;258	G;A;C	252;255;258	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5518	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3356	204.7	1	SNP	p	S87W	0	.	.	259	261	AGT	755	757	AGT	256;254;252	A;G;T,G	256;254;251,1	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5518	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3356	204.7	1	SNP	p	S87R	0	.	.	259	261	AGT	755	757	AGT	256;254;252	A;G;T,G	256;254;251,1	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5518	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3356	204.7	1	SNP	p	S87I	0	.	.	259	261	AGT	755	757	AGT	256;254;252	A;G;T,G	256;254;251,1	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5518	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3356	204.7	1	SNP	p	S88P	0	.	.	262	264	TCC	758	760	TCC	253;252;254	T;C;C	253;252;254	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4690	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3127	187.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1796	1798	GGC	253;255;256	G,C;G;C,A	250,1;255;254,2	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4390	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2965	184.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1642	1644	GCA	262;263;265	G;C;A,G	262;263;264,1	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4390	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2965	184.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1645	1647	ATC	265;267;271	A;T;C,G	265;267;270,1	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4390	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2965	184.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1657	1659	GTG	275;276;275	G,A;T,G;G,T	273,1;274,1;273,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4390	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2965	184.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1657	1659	GTG	275;276;275	G,A;T,G;G,T	273,1;274,1;273,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4390	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2965	184.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2161	2163	ACC	241;239;238	A,G;C;C,A	240,1;239;236,2	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4390	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2965	184.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2215	2217	GCG	224;223;221	G;C,G;G	224;221,2;221	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4390	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2965	184.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2215	2217	GCG	224;223;221	G;C,G;G	224;221,2;221	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4390	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2965	184.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2338	2340	GGC	244;245;245	G,A;G,A;C,A	243,1;244,1;244,1	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4390	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2965	184.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2347	2349	GGC	239;239;241	G;G,T;C	239;238,1;241	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4390	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2965	184.5	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2365	2367	CTG	246;248;249	C;T;G	246;248;249	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5964	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3544	209.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1903	1905	CCG	215;218;219	C,A;C,T,A;G	214,1;213,2,2;219	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2566	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2240	142.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	753	753	C	181	C	181	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	304	porB1a	984	155	92.26	porB1a.l15.c17.ctg.2	155	40.3	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	22;25;28	T;T;A	22;25;28	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	304	porB1a	984	155	92.26	porB1a.l15.c17.ctg.2	155	40.3	0	.	p	.	0	S271T	NONSYN	811	813	TCG	53	55	ACT	50;50;50	A;C;T	50;50;50	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	304	porB1a	984	155	92.26	porB1a.l15.c17.ctg.2	155	40.3	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	50;50;50	C;A;T,C	50;50;49,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	304	porB1a	984	155	92.26	porB1a.l15.c17.ctg.2	155	40.3	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	50;50;50	A;G;T	50;50;50	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	304	porB1a	984	155	92.26	porB1a.l15.c17.ctg.2	155	40.3	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	50;50;50	T;A;C	50;50;50	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	304	porB1a	984	100	94.0	porB1a.l15.c17.ctg.3	172	64.0	0	.	p	.	0	M18T	NONSYN	52	54	ATG	123	125	ACG	75;72;68	A;C;G	75;72;68	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	304	porB1a	984	100	94.0	porB1a.l15.c17.ctg.3	172	64.0	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	165	167	CAA	16;15;14	C;A;A	16;15;14	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3162	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1850	210.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	543	545	GAA	303;303;303	G;A,C;A	303;302,1;303	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3162	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1850	210.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	831	833	GAT	254;253;255	G;A,T,G;T	254;251,1,1;255	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3162	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1850	210.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	954	956	TCA	320;319;322	T;C,T,G;A	320;317,1,1;322	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3162	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1850	210.2	0	.	p	.	0	Q214L	NONSYN	640	642	CAA	1071	1073	CTA	245;245;243	C,G;T;A	244,1;245;243	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3162	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1850	210.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1083	1085	GTC	229;229;227	G,C;T,G,A;C,T,G	228,1;227,1,1;225,1,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3162	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1850	210.2	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1095	1097	TCT	228;232;233	T;C,T;T	228;231,1;233	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3162	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1850	210.2	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1305	1307	ACT	252;251;251	A,C;C;T	250,1;250;250	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3162	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1850	210.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1413	1415	GCA	236;235;236	G,T;C;A	235,1;235;236	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3162	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1850	210.2	1	SNP	p	G120K	1	.	.	358	360	AAG	789	791	AAG	240;238;235	A;A,C;G,A	240;237,1;234,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3162	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1850	210.2	1	SNP	p	A121D	1	.	.	361	363	GAC	792	794	GAC	234;237;237	G;A;C	234;236;237	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3162	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1850	210.2	1	SNP	p	D121N	0	.	.	361	363	GAC	792	794	GAC	234;237;237	G;A;C	234;236;237	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	11222	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5322	262.6	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2307	2309	AAT	266;266;269	A,C,G;A,C;T,G	264,1,1;265,1;267,2	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1648	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1494	137.5	1	SNP	p	V57M	1	.	.	169	171	ATG	774	776	ATG	265;263;266	A,C;T;G	264,1;263;266	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
